目的:本研究的目的是评估窄带成像(NBI)在监测头颈部癌治疗后的诊断性能,并与白光内窥镜(WLE)进行比较。
方法:PubMed,Embase,WebofScience(WOS),科克伦图书馆,中国生物医学光盘(CBM光盘),中国国民知识互联网(CNKI),万方数据,中国科技期刊数据库(CSTJ),中国临床试验注册。
方法:使用首选报告项目进行系统评价和荟萃分析(PRISMA),搜索了2024年7月之前发表的文献。接受手术的病人,放射治疗(RT),使用NBI分析治疗后随访的头颈部癌或化疗RT。主要结果是敏感性,特异性,治疗后随访中NBI和WLE的诊断比值比(DOR)。
结果:灵敏度,特异性,NBI和WLE在头颈部癌治疗后随访中的DOR为95%(95%置信区间[CI]:88%-98%),96%(95%CI:92%-98%),433(95%CI:120-1560)和72%(95%CI:49%-87%),72%(95%CI:4%-99%),7(95%CI:0-191)。此外,NBI和WLE的曲线下面积(AUC)值分别为0.99(95%CI:0.97-0.99)和0.75(95%CI:0.71-0.79),分别。病变和患者的数量,治疗方式,随访时间,疾病,和内窥镜系统可能是异质性的来源。
结论:与WLE相比,NBI在治疗后随访的头颈部癌患者中显示出优异的诊断性能。NBI为早期发现头颈部肿瘤复发提供技术支持和临床基础。
方法:NA喉镜,2024.
OBJECTIVE: The purpose of this study was to assess the diagnostic performance of narrow-band imaging (NBI) in monitoring patients with head and neck carcinomas posttreatment and to compare it with that of white light endoscopy (WLE).
METHODS: PubMed, Embase, Web of Science (WOS), Cochrane Library,
China Biology Medicine disc (CBM disc),
China National Knowledge Internet (CNKI), Wanfang Data,
China Science and Technology Journal Database (CSTJ), Chinese Clinical Trial Register.
METHODS: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), literature published before July 2024 was searched. Patients who underwent surgery, radiotherapy (RT), or chemo-RT for head and neck carcinomas with posttreatment follow-up using NBI were analyzed. The main outcomes were sensitivity, specificity, and diagnostic odds ratio (DOR) for NBI and WLE in posttreatment follow-up.
RESULTS: The sensitivity, specificity, and DOR for NBI and WLE in posttreatment follow-up for head and neck carcinomas were 95% (95% confidence interval [CI]: 88%-98%), 96% (95% CI: 92%-98%), 433 (95% CI: 120-1560) and 72% (95% CI: 49%-87%), 72% (95% CI: 4%-99%), 7 (95% CI: 0-191). Additionally, the area under the curve (AUC) values for NBI and WLE were 0.99 (95% CI: 0.97-0.99) and 0.75 (95% CI: 0.71-0.79), respectively. The number of lesions and patients, treatment modality, follow-up time, disease, and endoscopic system might be sources of heterogeneity.
CONCLUSIONS: Compared to WLE, NBI demonstrated superior diagnostic performance in follow-up patients with head and neck carcinoma posttreatment. NBI offers technical support and a clinical foundation for early detection of head and neck carcinoma recurrence.
METHODS: NA Laryngoscope, 2024.